Difficulties in the diagnosis and therapeutic approach in autoimmune polyglandular syndrome type 2. A clinical сase

Main Article Content

G.F. Gendeleka
A.N. Gendeleka

Abstract

Autoimmune polyglandular syndrome is characteri­zed by an immune-mediated destruction of endocrine tissues. The presence of autoimmune diseases of the endocrine system such as type 1 diabetes mellitus, adrenocortical failure and autoimmune thyroid disease is specific for autoimmune polyglandular syndrome type 2. In case of hormonal insufficiency, hormone replacement therapy is required.

Article Details

How to Cite
Gendeleka, G., and A. Gendeleka. “Difficulties in the Diagnosis and Therapeutic Approach in Autoimmune Polyglandular Syndrome Type 2. A Clinical сase”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 1, Mar. 2018, pp. 99-102, doi:10.22141/2224-0721.14.1.2018.127101.
Section
Clinical Case

References

Davydchyk EV, Snezhitskiy VA, Nikonova LV, Tishkovskiy SV. Endocrine aspects of polyglandular autoimmune syndromes. Journal of the Grodno State Medical University. 2016;2(54):15-21. (in Russian).

Larina AA, Shapoval’yants OS, Mazurina NV, Troshina EA. Diagnostics and treatment of polyglandular syndromes of adults. Klinicheskaya meditsina. 2012;90(8):64-66. (in Russian).

Betterle C, Dal Prata C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens and their applicability in diagnosis and disease prediction. Endocr Rev. 2002 Jun;23(3):327-64. doi: 10.1210/edrv.23.3.0466.

Carpenter C, Solomon N, Silverberg SG, et al. Schmidt's syndrome (thyroid and adrenal insufficiency). A review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine (Baltimore). 1964 Mar;43:153-80. PMID: 14132718.

Eisenbarth G, Gottlieb P. Autoimmune polyendocrine syndromes. N Engl J Med. 2004 May 13;350(20):2068-79. doi: 10.1056/NEJMra030158.